[What is the Best Therapeutic Strategy for Decompression Illness? First Aid Oxygen Inhalation and Hyperbaric Oxygen Therapy].


Journal

Journal of UOEH
ISSN: 0387-821X
Titre abrégé: J UOEH
Pays: Japan
ID NLM: 7909645

Informations de publication

Date de publication:
2021
Historique:
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 29 10 2021
Statut: ppublish

Résumé

Decompression illness (DCI), a syndrome following inadequate reduction in environmental pressure, has two forms: decompression sickness and arterial gas embolism after pulmonary barotrauma. Recompression therapy using oxygen, a kind of hyperbaric oxygen therapy, has been considered the gold standard treatment for DCI, although there is no randomized controlled trial evidence for its use. We evaluated the effectiveness of recompression therapy in treating DCI by reviewing the reported therapeutic results of serious DCI, especially neurological disorders. Early or ultra-early recompression therapy did not dramatically improve clinical recovery from DCI symptoms, including spinal cord disorders. In contrast, early first aid normobaric oxygen inhalation highly improved or stabilized clinical conditions of DCI. Based on these clinical results, the international committee for hyperbaric and diving medicine has stated that cases of mild DCI may be managed without recompression therapy. Further work is needed to clarify the clinical utility of recompression therapy for spinal injury as a common symptom of DCI. We also point out that the Japanese decree "Ordinance on Safety and Health of Work under High Pressure", which describes work under hyperbaric environments, has some serious issues and should be amended on the basis of scientific evidence.

Identifiants

pubmed: 34092769
doi: 10.7888/juoeh.43.243
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

243-254

Auteurs

Kiyotaka Kohshi (K)

Division of Neurosurgery, Nishinihon Hospital.
Department of Environmental Medicine, Kurume University School of Medicine.

Yoshitaka Morimatsu (Y)

Department of Environmental Medicine, Kurume University School of Medicine.

Hideharu Nishikiori (H)

Department of Environmental Medicine, Kurume University School of Medicine.
Chugoku Diving Company Limited.

Hideki Tamaki (H)

Department of Environmental Medicine, Kurume University School of Medicine.
Division of Surgery and Emergency Medicine, Tamaki Hospital.

Tatsuya Ishitake (T)

Department of Environmental Medicine, Kurume University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH